EGRX

0.65000.00%
MG

Michael Graves

CEO & Chairman

Mr. Michael Graves, also known as Mike, was Interim Principal Executive Officer of Eagle Pharmaceuticals, Inc. from 2023 to October 2025 and serves as its Chief Executive Officer since October 2025. He had been the Independent Chairman of Eagle Pharmaceuticals Inc. since June 2016 until November 29, 2023 and served as its Interim Executive Chairman since November 29, 2023 until October 2025 and serves as its Chairman since October 2025. He served as the Chief Executive Officer and President of Paddock Laboratories, Inc from May 2007 to July 2011. Mr. Graves was responsible for running the business on a day-to-day basis as well as focusing on Paddock Laboratories growth. He has an intense focus on business development and improving Paddock's research and development capabilities, he has enabled Paddock to sustain a sales growth of more than 30 percent per year. He served as President of the Generic Products Division at Par Pharmaceutical Companies Inc. from September 20, 2005 to November 15, 2006. Mr. Graves oversaw the strategy development of Par’s generic pharmaceutical business. Prior to this, he served as Senior Vice President of Corporate Development and Strategic Planning of Par Pharmaceutical Companies Inc. since 1998, he progressed through a series of promotions within marketing, sales, business development and operational responsibilities consistent with Chief Operations Officer. Mr. Graves served at D & K Healthcare Resources, Inc. and Cardinal Health, Inc. where his hands-on experience in marketing, sales, business development, purchasing, supply chain management and manufacturing helped him understand all aspects of the pharmaceutical business. In December 2011, Mr. Graves was appointed chairman of the board of directors at Nanocopoeia, Inc. both private pharmaceutical companies. He has been Director of Eagle Pharmaceuticals Inc since November 2013. Beginning in 1998, Mr. Graves served as director of marketing and sales operations of Par. He had been a Director of RiboCor, Inc, since January 2012. He is a member of the Board of Managers of TopRx, LLC. Mr. Graves holds a B.S. from State University College of New York at Buffalo.

Positions